Table 1.

Performance of three different cell line–derived dasatinib sensitivity (mDS) predictors in independent cell lines treated with dasatinib

Data setACCSensitivitySpecificityPPVNPVAUC
Weighted VotingBreast cancer (n = 12)0.9170.7501.0001.0000.8890.906
Lung cancer (n = 23)0.7390.9090.5830.6670.8750.818
CentroidBreast cancer (n = 12)0.9170.7501.0001.0000.8890.906
Lung cancer (n = 23)0.6960.4550.9170.8330.6470.833
SVMBreast cancer (n = 12)0.6670.0001.000NA0.6670.938
Lung cancer (n = 23)0.5220.0910.9170.5000.5240.758